- The Strategist - https://aspistrategist.ru -

Policy, Guns and Money: China’s talent recruitment, extremism and vaccine disinformation

Posted By on August 28, 2020 @ 16:23

In this episode, Alex Joske and Danielle Cave of ASPI’s International Cyber Policy Centre speak about Alex’s report [1], Hunting the Phoenix: The Chinese Communist Party’s global search for technology and talent, which examines China’s global recruitment programs for researchers and scientists. They talk about the scale of the programs and how governments can shape their policy responses to them.

ICPC researcher Elise Thomas and intern Albert Zhang then give a rundown on their latest report [2], which looks at disinformation about a Covid-19 vaccine that emerged from pro-Russian media in eastern Ukraine and managed to make its way across international social media networks.

And the head of ASPI’s counterterrorism program, Leanne Close, speaks to author and researcher Julia Ebner about her book [3], Going dark: The secret social lives of extremists. They discuss right-wing extremism and Julia details her experiences going undercover to engage with extremist groups and individuals.

Policy, Guns & Money: The ASPI Podcast [4] · Understanding right-wing extremism, China’s talent-recruitment & Covid-19 vaccine disinformation [5]


Article printed from The Strategist: https://aspistrategist.ru

URL to article: /policy-guns-and-money-chinas-talent-recruitment-extremism-and-vaccine-disinformation/

URLs in this post:

[1] report: http://www.aspistrategist.ru/report/hunting-phoenix

[2] report: http://www.aspistrategist.ru/report/covid-19-disinformation

[3] book: https://www.bloomsbury.com/uk/going-dark-9781526616784/

[4] Policy, Guns & Money: The ASPI Podcast: https://soundcloud.com/user-415599049

[5] Understanding right-wing extremism, China’s talent-recruitment & Covid-19 vaccine disinformation: https://soundcloud.com/user-415599049/understanding-right-wing-extremism-chinas-talent-recruitment-covid-19-vaccine-disinformation

Copyright © 2024 The Strategist. All rights reserved.